Hyperloop Transportation Technologies Signs First Cross-State Deal in the US

admin
admin
· 1 min read
Hyperloop Transportation Technologies signs first cross-state deal in the US

Hyperloop Transportation Technologies (HTT) has signed a deal with the North Ohio Areawide Coordinating Agency (NOACA) and Illinois’ Department of Transportation (IDOT) to start work on a feasibility study, the first step of determining whether it is possible to build a route before beginning work in earnest. The study will focus on determining the viability of a number of different corridors, with the goal of connecting Cleveland and Chicago.

This now stands as the “first real public-private partnership to bring Hyperloop travel to the US,” HTT CEO Dirk Ahlborn said in a statement.

HTT has agreements in place already with a number of other public partners worldwide, including in India and Europe. Most of the work is still in the planning phase.

In September 2017, HTT came to an agreement with the Andhra Pradesh Economic Development Board, to bring a Hyperloop system to in India. The proposed route for the Hyperloop is between the city centers of Vijayawada and Amravati, potentially turning a trip of more than one hour into a 5-minute ride. The project will use a Public Private Partnership (PPP) model with funding primarily from private investors.

Read Next

Apollo Hospitals Brings Advanced Super Speciality Care in Dadar
News
May 11, 2026

Apollo Hospitals Brings Advanced Super Speciality Care in Dadar

Apollo Hospitals has launched its Super Speciality Center in Dadar, bringing advanced medical care to the heart of Mumbai. The Centre offers super-speciality services across Cardiology, Neurology, Oncology, Gastroenterology, Orthopaedics, Transplantation and Pulmonology, supported by comprehensive diagnostics, robotics-enabled care, and 24×7 clinical access. Nearly 8,000 patients from Mumbai travel to Apollo Hospitals Navi Mumbai every […]
Article by: IMT News Desk
ICMR Invites Pharma Industry To Commercialise Indigenous Cervical Cancer Drug Candidate SHetA2
News
May 11, 2026

ICMR Invites Pharma Industry To Commercialise Indigenous Cervical Cancer Drug Candidate SHetA2

In a major boost to India’s fight against cervical cancer, the Indian Council of Medical Research (ICMR) has invited pharmaceutical companies and eligible organisations to partner in the development and commercialisation of an indigenous cervical cancer drug candidate, SHetA2, designed to treat HPV-induced cervical dysplasia and cervical cancer. ICMR has issued an Expression of Interest […]
Article by: IMT News Desk
Bodywell Ayurveda Earns Global Recognition Through Regulatory Compliance and Strategic Expansion
News
May 11, 2026

Bodywell Ayurveda Earns Global Recognition Through Regulatory Compliance and Strategic Expansion

Homegrown Ayurvedic brand Bodywell Ayurveda is announcing a series of milestones that position it as a regulatory-compliant player on the global wellness stage, built on years of operating within India’s stringent regulatory framework. The company, which holds valid Ayurveda and food manufacturing licences in full compliance with national regulatory standards, is now stocked in over […]
Article by: IMT News Desk
AIIMS Launches Low-Cost Advanced Test to Make Epilepsy Treatment Safer
News
May 11, 2026

AIIMS Launches Low-Cost Advanced Test to Make Epilepsy Treatment Safer

The All India Institute of Medical Sciences (AIIMS) has launched an advanced blood testing service that enables doctors to more accurately treat epilepsy patients and reduce the risk of medicine-related side effects. The new facility at AIIMS’ Neurosciences Centre will monitor the levels of two commonly used anti-epilepsy medicines, levetiracetam and lamotrigine, in a patient’s […]
Article by: IMT News Desk